OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CEO Aaron Green bought 36,920 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were acquired at an average cost of $0.56 per share, for a total transaction of $20,675.20. Following the transaction, the chief executive officer directly owned 1,841,023 shares in the company, valued at approximately $1,030,972.88. This represents a 2.05% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website.
Aaron Green also recently made the following trade(s):
- On Monday, June 15th, Aaron Green bought 18,702 shares of OneMedNet stock. The shares were acquired at an average cost of $0.54 per share, for a total transaction of $10,099.08.
OneMedNet Stock Performance
Shares of NASDAQ ONMD opened at $0.60 on Thursday. OneMedNet Corporation has a fifty-two week low of $0.33 and a fifty-two week high of $4.22. The firm has a market capitalization of $32.78 million, a PE ratio of -12.05 and a beta of 1.12. The stock’s 50-day simple moving average is $0.85 and its 200-day simple moving average is $0.95.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the company. HRT Financial LP acquired a new position in OneMedNet during the fourth quarter worth approximately $32,000. State Street Corp increased its position in OneMedNet by 41.5% during the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after buying an additional 34,200 shares during the period. Virtu Financial LLC acquired a new position in OneMedNet during the fourth quarter worth approximately $48,000. Exencial Wealth Advisors LLC grew its stake in shares of OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after purchasing an additional 45,401 shares during the last quarter. Finally, Jane Street Group LLC purchased a new position in shares of OneMedNet in the 4th quarter valued at approximately $119,000. Institutional investors and hedge funds own 0.95% of the company’s stock.
Analyst Ratings Changes
ONMD has been the topic of several research analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen lowered OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.
Get Our Latest Stock Report on OneMedNet
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Featured Articles
- Five stocks we like better than OneMedNet
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
